Doctor profile · Federal record

Dr. Christopher Jordan, DO

Medical Oncology Physician (CMS: Internal Medicine) · Hematology & Oncology Physician · Medical Oncology Physician · Medical Oncology Physician · Montrose, CO

  • NPI 1679523625
  • Accepts Medicare
  • 27 yrs in practice
  • Licensed in 3 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
816 S 5Th St
Montrose, CO 814015765
(970) 497-8001
fax (970) 240-7793
Additional location
5450 Clearfork Main St Ste 200
Fort Worth, TX 761093562
(682) 707-4545
fax (817) 804-8160
Additional location
855 Montgomery St
Fort Worth, TX 761072553
(817) 735-2220
Mailing address
5450 Clearfork Main St Ste 200
Fort Worth, TX 761093562

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
May 8, 2025
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (3)
Colorado #DR.0069658 · Texas #L1085 · Alabama #DO-986
Medicaid (4)
TX #1500738-01 · TX #1500738-02 · AL #009913293 · TX #150073803

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1679523625. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
68,885
Distinct HCPCS
10
Medicare allowed
$1,225,338
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 30,090 29 $1
J1602 Injection, golimumab, 1 mg, for intravenous use 14,300 22 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 10,576 24 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 7,230 38 $33
J0897 Injection, denosumab, 1 mg 1,980 13 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,026 38 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 475 158 $8
36415 Insertion of needle into vein for collection of blood sample 416 152 $8
80053 Blood test, comprehensive group of blood chemicals 389 148 $10
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 303 92 $63

In context: peer comparison

Among 1 peers in Montrose Medical Oncology Physician, average services per provider: 1,913. This provider delivers 36× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$190
Transactions
8
Manufacturers
7
Payer (manufacturer) Industry Txns Amount
Telix Pharmaceuticals 1 $36.62
Regeneron Healthcare Solutions, INC. 2 $35.59
Revance Therapeutics, INC. 1 $32.32
Rigel Pharmaceuticals, INC. 1 $30.11
E.R. Squibb & Sons, L.L.C. 1 $22.18
Gilead Sciences, INC. 1 $17.58
Astellas Pharma US INC 1 $15.39

By nature of payment

Food and Beverage
$190

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
129
Patients
0
Total drug cost
$236,789
Drug Type Claims Patients Total cost
Bicalutamide Generic 30 0 $537
Anastrozole Generic 27 0 $315
Allopurinol Generic 21 0 $201
Hydroxyurea Generic 21 0 $576
Xtandi (Enzalutamide) Brand 16 0 $224,781
Xarelto (Rivaroxaban) Brand 14 0 $10,379

Frequently asked questions

Auto-generated from federal data
What is Dr. Christopher Jordan's medical specialty?
Dr. Christopher Jordan practices Medical Oncology Physician in Montrose, CO.
Where does Dr. Christopher Jordan practice?
Dr. Christopher Jordan practices at 816 S 5Th St, Montrose, CO 814015765. Office phone: 9704978001.
What is Dr. Christopher Jordan's NPI?
Dr. Christopher Jordan's National Provider Identifier (NPI) is 1679523625, issued by NPPES.
Does Dr. Christopher Jordan accept Medicare assignment?
Yes. Dr. Christopher Jordan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Jordan commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.